We are live on ! Find out more
CTHR

Charles & Colvard Ltd

Delisted

CTHR was delisted on the 24th of April, 2025.

31 hedge funds and large institutions have $13.4M invested in Charles & Colvard Ltd in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less funds holding

Funds holding: 3431 (-3)

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

50% less capital invested

Capital invested by funds: $26.9M → $13.4M (-$13.4M)

Holders
31
Holders Change
-3
Holders Change %
-8.82%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
9
Closed
5
Calls
Puts
Net Calls
Net Calls Change

CTHR Hedge Fund Activity: Q1 2022 in Review

31 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Charles & Colvard Ltd (CTHR) for Q1 2022, worth a combined $13.4M — down 50% from $26.9M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CTHR and 3 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 6 added.

The largest buyer was Victory Capital Management, adding an estimated $240K. The largest seller was Acuitas Investments, exiting entirely with an estimated $1.59M sold.

  • 31 institutional investors held Charles & Colvard Ltd (CTHR) as of Q1 2022, down from 34 in Q4 2021.
  • Funds reported $13.4M of Charles & Colvard Ltd stock for Q1 2022, down 50% quarter-over-quarter.
  • 3 funds opened new Charles & Colvard Ltd positions in Q1 2022 and 5 closed out, a net change of -2 holders.
  • The largest Charles & Colvard Ltd buyer in Q1 2022 was Victory Capital Management, an estimated $240K added.
  • The largest Charles & Colvard Ltd seller in Q1 2022 was Acuitas Investments, an estimated $1.59M sold.

Based on aggregated 13F filings for Q1 2022.